An Online Pilates Program for People with Hypermobility: A Pragmatic Clinical Trial Looking at Function, Interoception, Kinesiophobia, and Physical Activity Levels
Abstract
Purpose: This study evaluated whether an independent, online modified Pilates program alters function, interoception (internal body awareness), activity levels, and kinesiophobia (fear of movement) in people with symptomatic joint hypermobility.
Patients and methods: This pragmatic clinical trial included and exercise group that did 8 weeks of modified Pilates and an 8-week waitlist control group. People with symptomatic hypermobility were asked to do an independent, online Pilates program designed specifically for people with hypermobility; each module was about 25 minutes, and participants were asked to do at least 3 days/week. Outcome measures included the Bristol Impact of Hypermobility (BIoH), International Physical Activity Questionnaire (IPAQ), Revised Body Awareness Questionnaire (BARQ), and Tampa Scale of Kinesiophobia (TSK). Clinical Trial # NCT07118865.
Results: A total of 420 participants completed questionnaires at 8 weeks: 200 completed 8 weeks of Pilates and 220 were on a waitlist. The Pilates group demonstrated statistically significant improvements in BIoH, BARQ, and TSK immediately after the intervention (p<0.001 for each) and compared to the control group (p<0.001 for each). Improvements in the Pilates group remained statistically significant at 6 months. IPAQ did not change for any group.
Conclusion: This online Pilates program for people with symptomatic hypermobility improved BIoH, BARQ, and TSK, though changes were modest. The exercises did not improve…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 420 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.